ARCHIVES

FDA Begins To Examine Its Role In Allowing Misleading Consumer Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

USC, Wisconsin Get Construction Grants Totaling $1.5 Million

March 23, 1990

Review Of Cancer, AIDS Drugs Starts At Jan. Meeting

December 2, 1988

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

NCI Budget 6% Below 1980 Level; Prevention, Groups, Lost Most

February 8, 1991

DRCCA Committee, ACCC, DeVita Reach Agreement On CCOP

October 16, 1981

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994